Analyst Ratings for Royalty Pharma (RPRX) [Neutrals]
RPRX Rating Summary
RPRX Price Target Summary
- Highest: $50.00 (Goldman Sachs)
- Lowest: $38.00 (BofA Securities)
- Average: $43.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$43.40 (+56.6%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/14/2020 | Evercore ISI | Umer Raffat | New Coverage | In Line (N/A) |
N/A (N/A) |
47.64 (27.71) |
-41.83% | Details |
| 7/18/2017 | Laidlaw | N/A | Downgrade | Hold (Buy) |
N/A (N/A) |
0.39 (27.71) |
7005.13% | Details |
 |
||||||||
|
||||||||
